Brand Probability File
Take the Mystery Out of Brand-versus-generic Determinations
Making determinations on a drug product’s brand or generic status is complex. That’s why this file includes:
- Multiple data elements to support establishing proprietary rules
- A means of weighting the importance of each element when making brand/generic status decisions
- A Brand Probability Percent Value that can be utilized in your own algorithm or serve as a validation mechanism in your processing
What It Does for Your Business
- Empowers payers by providing statistical data to support brand-versus-generic formulary decisions
- Helps increase efficiency by providing simplified access to the data that drives brand-versus-generic product decisions
- Provides a way to validate your proprietary algorithms
What It Provides
- New and existing data sources, including:
- Drug Application Type (NDA, ANDA)
- CMS Drug Category Code
- Multi-source Code
- FDA Orange Book Reference Listed Drug
- Many others
- A weighted algorithm to establish a Brand Probability Percent Value for a drug product
- History file that enables probability score changes to be tracked over time
Delivery Timing Options
- Core Drug Files
- Pricing & Reimbursement
- Drug Attributes
- Patient Education
- Patient Safety
- Clinical Screening
- Hazardous Drug Handling
- Data Analytics
- Medication Therapy Management
- Interchangeability & Biosimilars
- Integrated Reference
- All Databases
- All APIs
Need more information?
Call us at 855.633.0577 or fill out our online form and we'll have someone contact you!
of customers are satisfied with the quality of Medi-Span data
of customers are likely to renew their Medi-Span data license
Hundreds of customers see 50% or greater increase in productivity with Medi-Span
See why more healthcare businesses are choosing Medi-Span for their drug data:
Speed to Market
Medi-Span implementation support helped save me one month in speed to market and about $10,000 in development costs.
Medi-Span, in my view, beats everyone else. It helps you find twice as many drug errors – errors that would lead to readmission - in half the amount of time.
(Medi-Span) allows us to provide features that our competitors do not have.
As a claims processor, we rely on Medi-Span and its wealth of drug information to forecast and price claims for our clients. Medi-Span is the go-to (application) that is recognized across the industry for (manufacturer-provided) drug information. They have innovative tools and excellent customer service that will go above and beyond to provide the best available solution.
Medi-Span implementation support helped save me one month in speed to market and about $10,000 in development costs.”
Consistent Pricing Data
It is the source for the benchmark prices consistently used in the PBM industry and the tool we use to hold PBMs accountable to their pricing promises to our employers.
Business cannot survive without Medi-Span data.
Only reliable published resource for (manufacturer-provided) AWP. (Medi-Span proprietary) GPI is therapeutic classification system of choice. It is very enabling, as clinical management rules are easily articulated.
Even in an era where data abounds, there is a terrific amount of uncertainty. People want confidence that what they are seeing is (based on) real (manufacturer-provided information) – Medi-Span provides that confidence.
(Medi-Span) allows for consistency across the company, industry and clients.
Timely and Relevant
The Medi-Span database allows our system to have the latest and most current information available. It is especially needed for package information, interaction checking, and clinical printing.
This is a foundational piece that is used throughout the organization in many systems and is often used to connect data from multiple systems.
Who is Clinical Drug Information?
With the move to team-based care, conflicting data can lead to actual conflicts – from disparity in business decisions to confusion in communication. We research, validate, and synthesize content to show the right data to right people at the right time. With content developed in a consistent manner across all platforms and resources, your team receives aligned drug information no matter when or how they access it. This helps:
- Improve communication
- Reduce confusion
- Enhance patient care
Impacting thousands of healthcare organizations - see our storyPlay Video
How can our award-winning drug data help you?
Learn more about Medi-Span